Anomalous Venous Blood Flow and Iron Deposition in Multiple Sclerosis

Multiple sclerosis (MS) is primarily an autoimmune disorder of unknown origin. This review focuses iron overload and oxidative stress as surrounding cause that leads to immunomodulation in chronic MS. Iron overload has been demonstrated in MS lesions, as a feature common with other neurodegenerative disorders. However, the recent description of chronic cerebrospinal venous insufficiency (CCSVI) associated to MS, with significant anomalies in cerebral venous outflow hemodynamics, permit to propose a parallel with chronic venous disorders (CVDs) in the mechanism of iron deposition. Abnormal cerebral venous reflux is peculiar to MS, and was not found in a miscellaneous of patients affected by other neurodegenerative disorders characterized by iron stores, such as Parkinson's, Alzheimer's, amyotrophic lateral sclerosis. Several recently published studies support the hypothesis that MS progresses along the venous vasculature. The peculiarity of CCSVI-related cerebral venous blood flow disturbances, together with the histology of the perivenous spaces and recent findings from advanced magnetic resonance imaging techniques, support the hypothesis that iron deposits in MS are a consequence of altered cerebral venous return and chronic insufficient venous drainage.

[1]  J. Norgauer,et al.  Inflammation in stasis dermatitis upregulates MMP-1, MMP-2 and MMP-13 expression. , 2001, Journal of dermatological science.

[2]  G. Perry,et al.  Metal ions and oxidative protein modification in neurological disease. , 2005, Annali dell'Istituto superiore di sanita.

[3]  B. Todorich,et al.  Oligodendrocytes and myelination: The role of iron , 2009, Glia.

[4]  M. Kaps,et al.  Comparison of transcranial color-coded duplex sonography and cranial CT measurements for determining third ventricle midline shift in space-occupying stroke. , 1999, AJNR. American journal of neuroradiology.

[5]  L. Rashed,et al.  The role of iron dysregulation in the pathogenesis of multiple sclerosis: an Egyptian study , 2008, Multiple sclerosis.

[6]  G. Johnson,et al.  Microvascular Abnormality in Relapsing-remitting Multiple Sclerosis: Perfusion Mr Imaging Findings in Normal-appearing White Matter , 2003 .

[7]  M. Filippi,et al.  Inflammation in multiple sclerosis: the good, the bad, and the complex , 2002, The Lancet Neurology.

[8]  E. Haacke,et al.  Susceptibility-Weighted Imaging: Technical Aspects and Clinical Applications, Part 1 , 2008, American Journal of Neuroradiology.

[9]  Ya Ke,et al.  Iron misregulation in the brain: a primary cause of neurodegenerative disorders , 2003, The Lancet Neurology.

[10]  E. Hatzimichael,et al.  Serum ferritin, transferrin and soluble transferrin receptor levels in multiple sclerosis patients , 2005, Multiple sclerosis.

[11]  J. Connor,et al.  Iron in the brain. , 2009, Nutrition reviews.

[12]  S. De Angelis,et al.  Iron regulates T-lymphocyte sensitivity to the IFN- /STAT1 signaling pathway in vitro and in vivo , 2004 .

[13]  Alireza Minagar,et al.  Multiple sclerosis as a vascular disease , 2006, Neurological research.

[14]  K. Scharffetter-Kochanek,et al.  Selective pick-up of increased iron by deferoxamine-coupled cellulose abrogates the iron-driven induction of matrix-degrading metalloproteinase 1 and lipid peroxidation in human dermal fibroblasts in vitro: a new dressing concept. , 2001, The Journal of investigative dermatology.

[15]  J. Brown The role of the fibrin cuff in the development of venous leg ulcers. , 2005, Journal of wound care.

[16]  J. Sullivan Is stored iron safe? , 2004, The Journal of laboratory and clinical medicine.

[17]  B. Schaller,et al.  Physiology of cerebral venous blood flow: from experimental data in animals to normal function in humans , 2004, Brain Research Reviews.

[18]  P. Zamboni The Big Idea: Iron-Dependent Inflammation in Venous Disease and Proposed Parallels in Multiple Sclerosis , 2006 .

[19]  G. Gardiner Obstructive lesions of the inferior vena cava: Clinical features and endovenous treatment , 2008 .

[20]  S. Zuehlsdorff,et al.  4D Radial Acquisition Contrast-Enhanced MR Angiography and Intracranial Arteriovenous Malformations: Quickly Approaching Digital Subtraction Angiography , 2009, Stroke.

[21]  M. Cambron,et al.  Vascular aspects of multiple sclerosis , 2011, The Lancet Neurology.

[22]  P. Zamboni The Big Idea: Iron-Dependent Inflammation in Venous Disease and Proposed Parallels in Multiple Sclerosis , 2006, Journal of the Royal Society of Medicine.

[23]  R. Floyd,et al.  Regional lipid peroxidation in rat brain in vitro: Possible role of endogenous iron , 1985, Neurochemical Research.

[24]  K. Ikematsu,et al.  Age-associated increases in heme oxygenase-1 and ferritin immunoreactivity in the autopsied brain. , 2003, Legal medicine.

[25]  J. Connor,et al.  Iron, brain ageing and neurodegenerative disorders , 2004, Nature Reviews Neuroscience.

[26]  G. Stoll,et al.  Imaging of inflammation in the peripheral and central nervous system by magnetic resonance imaging , 2009, Neuroscience.

[27]  B E Kendall,et al.  Breakdown of the blood-brain barrier precedes symptoms and other MRI signs of new lesions in multiple sclerosis. Pathogenetic and clinical implications. , 1990, Brain : a journal of neurology.

[28]  Rohit Bakshi,et al.  Role of MRI in multiple sclerosis II: brain and spinal cord atrophy. , 2004, Frontiers in bioscience : a journal and virtual library.

[29]  K. Burnand,et al.  THE CAUSE OF VENOUS ULCERATION , 1982, The Lancet.

[30]  S. LeVine,et al.  The Role of Iron in the Pathogenesis of Experimental Allergic Encephalomyelitis and Multiple Sclerosis , 2004, Annals of the New York Academy of Sciences.

[31]  M. Muckenthaler,et al.  Iron toxicity in diseases of aging: Alzheimer's disease, Parkinson's disease and atherosclerosis. , 2009, Journal of Alzheimer's disease : JAD.

[32]  G. Porto,et al.  Iron overload and immunity. , 2007, World journal of gastroenterology.

[33]  S. Naylor,et al.  Human transferrin: cDNA characterization and chromosomal localization. , 1984, Proceedings of the National Academy of Sciences of the United States of America.

[34]  F. Salvi,et al.  Chronic cerebrospinal venous insufficiency in patients with multiple sclerosis , 2008, Journal of Neurology, Neurosurgery, and Psychiatry.

[35]  D. Ethell,et al.  Matrix metalloproteinase-7 facilitates immune access to the CNS in experimental autoimmune encephalomyelitis , 2009, BMC Neuroscience.

[36]  Z. Wu,et al.  Susceptibility-Weighted Imaging: Technical Aspects and Clinical Applications, Part 2 , 2008, American Journal of Neuroradiology.

[37]  Horst Urbach,et al.  4D time‐resolved MR angiography with keyhole (4D‐TRAK): More than 60 times accelerated MRA using a combination of CENTRA, keyhole, and SENSE at 3.0T , 2008, Journal of magnetic resonance imaging : JMRI.

[38]  M. Atkinson,et al.  An Integral Role for Heme Oxygenase-1 and Carbon Monoxide in Maintaining Peripheral Tolerance by CD4+CD25+ Regulatory T Cells 1 , 2005, The Journal of Immunology.

[39]  C. Levenson,et al.  Iron and ageing: an introduction to iron regulatory mechanisms , 2004, Ageing Research Reviews.

[40]  R. Poston,et al.  Pathology, histochemistry and immunocytochemistry of lesions in acute multiple sclerosis , 1989, Journal of the Neurological Sciences.

[41]  Ernest Beutler,et al.  Brain Iron Metabolism and Neurodegenerative Disorders , 2002, Developmental Neuroscience.

[42]  N. Abdelrahman,et al.  Comparison of Three Different Methods for Measurement of Cervical Cord Atrophy in Multiple Sclerosis , 2008, American Journal of Neuroradiology.

[43]  C. Bunker,et al.  Leukocytes: their role in the etiopathogenesis of skin damage in venous disease. , 1993, Journal of vascular surgery.

[44]  J R Reichenbach,et al.  In vivo measurement of blood oxygen saturation using magnetic resonance imaging: A direct validation of the blood oxygen level‐dependent concept in functional brain imaging , 1997, Human brain mapping.

[45]  E. Frohman,et al.  Multiple sclerosis--the plaque and its pathogenesis. , 2006, The New England journal of medicine.

[46]  M. Barnett,et al.  The pathology of multiple sclerosis: a paradigm shift , 2006, Current opinion in neurology.

[47]  F. Carinci,et al.  Venous collateral circulation of the extracranial cerebrospinal outflow routes. , 2009, Current neurovascular research.

[48]  S. Tognazzo,et al.  The overlapping of local iron overload and HFE mutation in venous leg ulcer pathogenesis. , 2006, Free radical biology & medicine.

[49]  Rohit Bakshi,et al.  Iron in chronic brain disorders: Imaging and neurotherapeutic implications , 2007, Neurotherapeutics.

[50]  C. W. Tjoa,et al.  MRI T2 hypointensity of the dentate nucleus is related to ambulatory impairment in multiple sclerosis , 2005, Journal of the Neurological Sciences.

[51]  E. Haacke,et al.  Imaging iron stores in the brain using magnetic resonance imaging. , 2005, Magnetic resonance imaging.

[52]  S. Tognazzo,et al.  Serum Iron and Matrix Metalloproteinase‐9 Variations in Limbs Affected by Chronic Venous Disease and Venous Leg Ulcers , 2005, Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.].

[53]  J. Olynyk,et al.  The Regulation of Cellular Iron Metabolism , 2007, Critical reviews in clinical laboratory sciences.

[54]  T. Rouault,et al.  Iron on the brain , 2001, Nature Genetics.

[55]  M. Ursino,et al.  A simple mathematical model of the interaction between intracranial pressure and cerebral hemodynamics. , 1997, Journal of applied physiology.

[56]  K. Einhäupl,et al.  Assessment of normal flow velocity in basal cerebral veins. A transcranial doppler ultrasound study. , 1996, Stroke.

[57]  A. Pandit,et al.  The use of therapeutic gene eNOS delivered via a fibrin scaffold enhances wound healing in a compromised wound model. , 2008, Biomaterials.

[58]  S. Nelson,et al.  Quantitative in vivo magnetic resonance imaging of multiple sclerosis at 7 Tesla with sensitivity to iron , 2008, Annals of neurology.

[59]  J. Beard,et al.  Iron-deficient mice fail to develop autoimmune encephalomyelitis. , 2003, The Journal of nutrition.

[60]  Peter K Stys,et al.  Virtual hypoxia and chronic necrosis of demyelinated axons in multiple sclerosis , 2009, The Lancet Neurology.

[61]  Paolo Zamboni,et al.  Intracranial venous haemodynamics in multiple sclerosis. , 2007, Current neurovascular research.

[62]  R. Erasmus,et al.  Biochemical Model for Inflammation of the Brain: The Effect of Iron and Transferrin on Monocytes and Lipid Peroxidation , 2004, Metabolic Brain Disease.

[63]  C. Exley,et al.  Elevated urinary excretion of aluminium and iron in multiple sclerosis , 2006, Multiple sclerosis.

[64]  P. Zamboni,et al.  Inflammation in venous disease. , 2008, International angiology : a journal of the International Union of Angiology.

[65]  J. Raffetto Dermal pathology, cellular biology, and inflammation in chronic venous disease. , 2009, Thrombosis research.

[66]  C. Franceschi The unsolved puzzle of multiple sclerosis and venous function , 2008, Journal of Neurology, Neurosurgery, and Psychiatry.

[67]  Young Wook Kim,et al.  Primary Budd-Chiari syndrome: outcome of endovascular management for suprahepatic venous obstruction. , 2006, Journal of vascular surgery.

[68]  E. Spuentrup,et al.  High spatial resolution magnetic resonance imaging of experimental cerebral venous thrombosis with a blood pool contrast agent. , 2010, European journal of radiology.

[69]  A. Bush,et al.  Metals and neuroscience. , 2000, Current opinion in chemical biology.

[70]  T. Gadelha,et al.  Normal plasma antithrombin activity in patients with relapsing–remitting and secondary progressive multiple sclerosis , 2009, Clinical Neurology and Neurosurgery.

[71]  A. Compston,et al.  Multiple sclerosis. , 2002, Lancet.

[72]  A. Lutterotti,et al.  Plasma levels of soluble adhesion molecules sPECAM-1, sP-selectin and sE-selectin are associated with relapsing-remitting disease course of multiple sclerosis , 2005, Journal of Neuroimmunology.

[73]  F. Kirchhoff,et al.  Glia: the fulcrum of brain diseases , 2007, Cell Death and Differentiation.

[74]  M. Filippi,et al.  T2 hypointensity in the deep gray matter of patients with benign multiple sclerosis , 2009, Multiple sclerosis.

[75]  E. Granieri,et al.  Cerebrospinal fluid and serum levels and intrathecal production of active matrix metalloproteinase-9 (MMP-9) as markers of disease activity in patients with multiple sclerosis , 2006, Multiple sclerosis.

[76]  B. Drayer,et al.  Reduced signal intensity on MR images of thalamus and putamen in multiple sclerosis: increased iron content? , 1987, AJR. American journal of roentgenology.

[77]  P. Zamboni,et al.  Urine hemosiderin: a novel marker to assess the severity of chronic venous disease. , 2003, Journal of vascular surgery.

[78]  Paolo Zamboni,et al.  The value of cerebral Doppler venous haemodynamics in the assessment of multiple sclerosis , 2009, Journal of the Neurological Sciences.

[79]  I. Allen,et al.  THE PATHOLOGY OF MULTIPLE SCLEROSIS‐FACT, FICTION AND HYPOTHESIS , 1981, Neuropathology and applied neurobiology.

[80]  C. W. Adams,et al.  Perivascular iron deposition and other vascular damage in multiple sclerosis. , 1988, Journal of neurology, neurosurgery, and psychiatry.

[81]  R. Grossman,et al.  Characterizing iron deposition in multiple sclerosis lesions using susceptibility weighted imaging , 2009, Journal of magnetic resonance imaging : JMRI.

[82]  Manu O. Platt,et al.  Bone Morphogenic Protein 4 Produced in Endothelial Cells by Oscillatory Shear Stress Induces Monocyte Adhesion by Stimulating Reactive Oxygen Species Production From a Nox1-Based NADPH Oxidase , 2004, Circulation research.

[83]  O. Bagasra,et al.  Prevention of experimental allergic encephalomyelitis by targeting nitric oxide and peroxynitrite: implications for the treatment of multiple sclerosis. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[84]  W. L. Benedict,et al.  Multiple Sclerosis , 2007, Journal - Michigan State Medical Society.

[85]  Paolo Zamboni,et al.  Doppler haemodynamics of cerebral venous return. , 2008, Current neurovascular research.

[86]  F. Barkhof,et al.  Cortical lesions in multiple sclerosis. , 1999, Brain : a journal of neurology.

[87]  J. Stankiewicz,et al.  Role of iron in neurotoxicity: a cause for concern in the elderly? , 2009, Current opinion in clinical nutrition and metabolic care.

[88]  F Barkhof,et al.  MR venography of multiple sclerosis. , 2000, AJNR. American journal of neuroradiology.

[89]  Z. Rybak,et al.  Hypothetical molecular mechanisms by which local iron overload facilitates the development of venous leg ulcers and multiple sclerosis lesions. , 2008, Medical hypotheses.

[90]  G. Schmid-Schönbein,et al.  Chronic venous disease. , 2006, Minerva cardioangiologica.

[91]  T. Fog The topography of plaques in multiple sclerosis with special reference to cerebral plaques. , 1965, Acta neurologica Scandinavica. Supplementum.

[92]  T. J. Putnam LESIONS OF ENCEPHALOMYELITIS AND MULTIPLE SCLEROSIS: VENOUS THROMBOSIS AS THE PRIMARY ALTERATION , 1937 .

[93]  D. Chari,et al.  Remyelination In Multiple Sclerosis , 2007, International Review of Neurobiology.

[94]  P. Ponka,et al.  Dysregulation of Iron Homeostasis in the CNS Contributes to Disease Progression in a Mouse Model of Amyotrophic Lateral Sclerosis , 2009, The Journal of Neuroscience.

[95]  F. Barkhof,et al.  Use of ultrasmall superparamagnetic particles of iron oxide (USPIO)‐enhanced MRI to demonstrate diffuse inflammation in the normal‐appearing white matter (NAWM) of multiple sclerosis (MS) patients: An exploratory study , 2009, Journal of magnetic resonance imaging : JMRI.

[96]  J. Caillé,et al.  MR imaging of relapsing multiple sclerosis patients using ultra-small-particle iron oxide and compared with gadolinium. , 2006, AJNR. American journal of neuroradiology.

[97]  A. Koeppen,et al.  The history of iron in the brain , 1995, Journal of the Neurological Sciences.

[98]  Frederik Barkhof,et al.  Pluriformity of inflammation in multiple sclerosis shown by ultra-small iron oxide particle enhancement. , 2008, Brain : a journal of neurology.